Gene Review:
SPINT1 - serine peptidase inhibitor, Kunitz type 1
Homo sapiens
Synonyms:
HAI, HAI-1, HAI1, Hepatocyte growth factor activator inhibitor type 1, Kunitz-type protease inhibitor 1, ...
Itoh,
Yamauchi,
Kataoka,
Hamasuna,
Kitamura,
Koono,
Kataoka,
Shimomura,
Kawaguchi,
Hamasuna,
Itoh,
Kitamura,
Miyazawa,
Koono,
Kataoka,
Meng,
Itoh,
Hamasuna,
Shimomura,
Suganuma,
Koono,
Nagakawa,
Yamagishi,
Akashi,
Nagaike,
Fuse,
Parr,
Jiang,
Kirchhofer,
Peek,
Li,
Stamos,
Eigenbrot,
Kadkhodayan,
Elliott,
Corpuz,
Lazarus,
Moran,
- Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr, C., Jiang, W.G. Int. J. Cancer (2006)
- Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. Kirchhofer, D., Peek, M., Li, W., Stamos, J., Eigenbrot, C., Kadkhodayan, S., Elliott, J.M., Corpuz, R.T., Lazarus, R.A., Moran, P. J. Biol. Chem. (2003)
- Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer. Nagakawa, O., Yamagishi, T., Akashi, T., Nagaike, K., Fuse, H. Prostate (2006)
- White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues. Yamada, T., Tsujioka, Y., Taguchi, J., Takahashi, M., Tsuboi, Y., Shimomura, T. Exp. Neurol. (1998)
- HAI enters its first at-risk contract to manage mental health for MetLife. Bartels-Rabb, L. Contract healthcare. (1988)
- Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Tanaka, H., Nagaike, K., Takeda, N., Itoh, H., Kohama, K., Fukushima, T., Miyata, S., Uchiyama, S., Uchinokura, S., Shimomura, T., Miyazawa, K., Kitamura, N., Yamada, G., Kataoka, H. Mol. Cell. Biol. (2005)
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. Kiyomiya, K., Lee, M.S., Tseng, I.C., Zuo, H., Barndt, R.J., Johnson, M.D., Dickson, R.B., Lin, C.Y. Am. J. Physiol., Cell Physiol. (2006)
- Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. Itoh, H., Kataoka, H. J. Gastroenterol. (2002)
- Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. Rougier, P., Laplanche, A., Huguier, M., Hay, J.M., Ollivier, J.M., Escat, J., Salmon, R., Julien, M., Roullet Audy, J.C., Gallot, D. J. Clin. Oncol. (1992)
- Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients. Earlam, S., Glover, C., Davies, M., Fordy, C., Allen-Mersh, T.G. J. Clin. Oncol. (1997)
- The cytotrophoblast layer of human chorionic villi becomes thinner but maintains its structural integrity during gestation. Mori, M., Ishikawa, G., Luo, S.S., Mishima, T., Goto, T., Robinson, J.M., Matsubara, S., Takeshita, T., Kataoka, H., Takizawa, T. Biol. Reprod. (2007)
- Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. Kataoka, H., Shimomura, T., Kawaguchi, T., Hamasuna, R., Itoh, H., Kitamura, N., Miyazawa, K., Koono, M. J. Biol. Chem. (2000)
- Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes. Itoh, H., Yamauchi, M., Kataoka, H., Hamasuna, R., Kitamura, N., Koono, M. Eur. J. Biochem. (2000)
- Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta. Kataoka, H., Meng, J.Y., Itoh, H., Hamasuna, R., Shimomura, T., Suganuma, T., Koono, M. Histochem. Cell Biol. (2000)
- Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. Lee, M.S., Kiyomiya, K., Benaud, C., Dickson, R.B., Lin, C.Y. Am. J. Physiol., Cell Physiol. (2005)
- Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis. Yamauchi, M., Itoh, H., Naganuma, S., Koono, M., Hasui, Y., Osada, Y., Kataoka, H. Biol. Chem. (2002)
- Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. Denda, K., Shimomura, T., Kawaguchi, T., Miyazawa, K., Kitamura, N. J. Biol. Chem. (2002)
- HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Oberst, M.D., Chen, L.Y., Kiyomiya, K., Williams, C.A., Lee, M.S., Johnson, M.D., Dickson, R.B., Lin, C.Y. Am. J. Physiol., Cell Physiol. (2005)
- Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. Fan, B., Wu, T.D., Li, W., Kirchhofer, D. J. Biol. Chem. (2005)
- Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Oberst, M., Anders, J., Xie, B., Singh, B., Ossandon, M., Johnson, M., Dickson, R.B., Lin, C.Y. Am. J. Pathol. (2001)
- Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Oberst, M.D., Johnson, M.D., Dickson, R.B., Lin, C.Y., Singh, B., Stewart, M., Williams, A., al-Nafussi, A., Smyth, J.F., Gabra, H., Sellar, G.C. Clin. Cancer Res. (2002)